Clinical Trial Update: A Study of Efficacy and Safety of Intravenous Cefiderocol (S-649266) Versus Imipenem/Cilastatin in Complicated Urinary Tract Infections [Phase 2]

View source ↗

Summary

Phase 2 trial comparing intravenous cefiderocol to imipenem/cilastatin for complicated urinary tract infections has completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complicated Urinary Tract Infection
• Urinary Tract Infection

Drugs mentioned

• Cefiderocol (cefiderocol)
• Imipenem/Cilastatin (imipenem/cilastatin)

Snippet

Sponsor: Shionogi | Conditions: Urinary Tract Infections | Phase 2 | Status: COMPLETED | Results posted: 2019-12-12